These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1104161)

  • 21. Growth kinetics of minimal tumour masses: implications for rational chemotherapy.
    Pileri A; Boccadoro M; Mandelli F; Amadori S
    Haematologica; 1981 Oct; 66(5):545-53. PubMed ID: 6796464
    [No Abstract]   [Full Text] [Related]  

  • 22. The historical development of cancer chemotherapy.
    Burchenal JH
    Semin Oncol; 1977 Jun; 4(2):135-46. PubMed ID: 327552
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell cycle dependent response and combined treatment of tumor.
    Terasima T; Ohara H; Miyamoto T; Watanabe M; Takabe Y; Watanabe I
    Jpn J Antibiot; 1977 Dec; 30 Suppl():49-56. PubMed ID: 77340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interaction of anticancer agents: a cellular perspective.
    Valeriote F; Lin Hs
    Cancer Chemother Rep; 1975; 59(5):895-900. PubMed ID: 1203896
    [No Abstract]   [Full Text] [Related]  

  • 25. Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cell phenotypic diversification?
    Lotan R; Nicolson GL
    Biochem Pharmacol; 1988 Jan; 37(2):149-54. PubMed ID: 3277636
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines.
    van Iersel LB; Koudijs TM; Hoekman EJ; Janssen-van Rhijn CM; Vahrmeijer AL; Nortier JW; van de Velde CJ; Gelderblom H; Kuppen PJ
    J Surg Res; 2011 May; 167(2):273-8. PubMed ID: 20036390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Developments and problems of cytostatic chemotherapy].
    Gross R
    Internist (Berl); 1971; 12():Suppl 1:109-15. PubMed ID: 4944099
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined cancer radiotherapy and chemotherapy: The relevance of cell population kinetics and pharmacodynamics.
    Andrews JR
    Cancer Chemother Rep; 1969 Dec; 53(6):313-24. PubMed ID: 5384465
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood and neoplastic diseases. A rational approach to the chemotherapy of human malignant disease. I.
    Crowther D
    Br Med J; 1974 Oct; 4(5937):156-9. PubMed ID: 4529038
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose: a critical factor in cancer chemotherapy.
    Frei E; Canellos GP
    Am J Med; 1980 Oct; 69(4):585-94. PubMed ID: 6999898
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modern methods of therapeutic management of malignant proliferative disorders].
    Sroczyński J
    Wiad Lek; 1974 Nov; 27(22):1977-83. PubMed ID: 4613011
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antitumoral chemotherapy].
    Drochmans A
    Acta Clin Belg; 1974; 29(1):1-19. PubMed ID: 4596845
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer robustness: tumour tactics.
    Kitano H
    Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of anticancer agent activity by selective inhibition of rapidly proliferating tissues of the host.
    Stolfi RL; Martin DS
    Pharmacol Ther; 1991; 49(1-2):43-54. PubMed ID: 1712975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic implications of brain tumor cell kinetics.
    Hoshino T
    Natl Cancer Inst Monogr; 1977 Dec; 46():29-35. PubMed ID: 613227
    [No Abstract]   [Full Text] [Related]  

  • 36. Introduction to resistance to anticancer agents.
    Kruh GD
    Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
    [No Abstract]   [Full Text] [Related]  

  • 37. Are cell kinetic data relevant for the design of tumour chemotherapy schedules?
    van Putten LM
    Cell Tissue Kinet; 1974 Sep; 7(5):493-504. PubMed ID: 4607700
    [No Abstract]   [Full Text] [Related]  

  • 38. [Revisiting sensitization mechanisms in cancer thermochemotherapy].
    Matsumoto H
    Fukuoka Igaku Zasshi; 2009 Apr; 100(4):95-103. PubMed ID: 19562936
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proliferative ability of cell populations and treatment of neoplasms].
    Rajewsky MF
    Nowotwory; 1976; 26(3):153-62. PubMed ID: 980800
    [No Abstract]   [Full Text] [Related]  

  • 40. Principles of current cancer chemotherapy.
    Wiemann MC; Calabresi P
    Compr Ther; 1983 Mar; 9(3):46-52. PubMed ID: 6839689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.